Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 154

1.

Risk of extensive virological failure to the three original antiretroviral drug classes over long-term follow-up from the start of therapy in patients with HIV infection: an observational cohort study.

Phillips AN, Leen C, Wilson A, Anderson J, Dunn D, Schwenk A, Orkin C, Hill T, Fisher M, Walsh J, Pillay D, Bansi L, Gazzard B, Easterbrook P, Gilson R, Johnson M, Sabin CA; UK Collaborative HIV Cohort (CHIC) Study.

Lancet. 2007 Dec 8;370(9603):1923-8.

PMID:
18068516
2.

Prevalence of HIV infection among inpatients and outpatients in Department of Veterans Affairs health care systems: implications for screening programs for HIV.

Owens DK, Sundaram V, Lazzeroni LC, Douglass LR, Sanders GD, Taylor K, VanGroningen R, Shadle VM, McWhorter VC, Agoncillo T, Haren N, Nyland J, Tempio P, Khayr W, Dietzen DJ, Jensen P, Simberkoff MS, Bozzette SA, Holodniy M.

Am J Public Health. 2007 Dec;97(12):2173-8. Epub 2007 Oct 30.

3.

A study of sexuality and health among older adults in the United States.

Lindau ST, Schumm LP, Laumann EO, Levinson W, O'Muircheartaigh CA, Waite LJ.

N Engl J Med. 2007 Aug 23;357(8):762-74.

4.

Older age and the response to and tolerability of antiretroviral therapy.

Silverberg MJ, Leyden W, Horberg MA, DeLorenze GN, Klein D, Quesenberry CP Jr.

Arch Intern Med. 2007 Apr 9;167(7):684-91.

PMID:
17420427
5.

Expanded HIV screening in the United States: effect on clinical outcomes, HIV transmission, and costs.

Paltiel AD, Walensky RP, Schackman BR, Seage GR 3rd, Mercincavage LM, Weinstein MC, Freedberg KA.

Ann Intern Med. 2006 Dec 5;145(11):797-806.

PMID:
17146064
6.

Characteristics of persons with heterosexually acquired HIV infection, United States 1999-2004.

Espinoza L, Hall HI, Hardnett F, Selik RM, Ling Q, Lee LM.

Am J Public Health. 2007 Jan;97(1):144-9. Epub 2006 Nov 30.

7.

Antiretroviral treatment and age-related comorbidities in a cohort of older HIV-infected patients.

Orlando G, Meraviglia P, Cordier L, Meroni L, Landonio S, Giorgi R, Fasolo M, Faggion I, Riva A, Zambelli A, Beretta R, Gubertini G, Dedivitiis G, Jacchetti G, Cargnel A.

HIV Med. 2006 Nov;7(8):549-57.

8.

Epidemiological and clinical features, response to HAART, and survival in HIV-infected patients diagnosed at the age of 50 or more.

Nogueras M, Navarro G, Antón E, Sala M, Cervantes M, Amengual M, Segura F.

BMC Infect Dis. 2006 Nov 6;6:159.

9.

Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings.

Branson BM, Handsfield HH, Lampe MA, Janssen RS, Taylor AW, Lyss SB, Clark JE; Centers for Disease Control and Prevention (CDC).

MMWR Recomm Rep. 2006 Sep 22;55(RR-14):1-17; quiz CE1-4.

10.

Rapid HIV testing at home: does it solve a problem or create one?

Walensky RP, Paltiel AD.

Ann Intern Med. 2006 Sep 19;145(6):459-62. Review.

PMID:
16983134
11.

Distribution of health care expenditures for HIV-infected patients.

Chen RY, Accortt NA, Westfall AO, Mugavero MJ, Raper JL, Cloud GA, Stone BK, Carter J, Call S, Pisu M, Allison J, Saag MS.

Clin Infect Dis. 2006 Apr 1;42(7):1003-10. Epub 2006 Feb 22.

PMID:
16511767
12.

HIV infection in older patients in the HAART era.

Grabar S, Weiss L, Costagliola D.

J Antimicrob Chemother. 2006 Jan;57(1):4-7. Epub 2005 Nov 11. Review.

PMID:
16284223
13.

Estimating the proportion of patients infected with HIV who will die of comorbid diseases.

Braithwaite RS, Justice AC, Chang CC, Fusco JS, Raffanti SR, Wong JB, Roberts MS.

Am J Med. 2005 Aug;118(8):890-8.

PMID:
16084183
14.

Expanded screening for HIV in the United States--an analysis of cost-effectiveness.

Paltiel AD, Weinstein MC, Kimmel AD, Seage GR 3rd, Losina E, Zhang H, Freedberg KA, Walensky RP.

N Engl J Med. 2005 Feb 10;352(6):586-95.

15.

Cost-effectiveness of screening for HIV in the era of highly active antiretroviral therapy.

Sanders GD, Bayoumi AM, Sundaram V, Bilir SP, Neukermans CP, Rydzak CE, Douglass LR, Lazzeroni LC, Holodniy M, Owens DK.

N Engl J Med. 2005 Feb 10;352(6):570-85.

16.

Immunologic and clinical responses to highly active antiretroviral therapy over 50 years of age. Results from the French Hospital Database on HIV.

Grabar S, Kousignian I, Sobel A, Le Bras P, Gasnault J, Enel P, Jung C, Mahamat A, Lang JM, Costagliola D.

AIDS. 2004 Oct 21;18(15):2029-38.

PMID:
15577624
17.

Older age does not influence CD4 cell recovery in HIV-1 infected patients receiving highly active antiretroviral therapy.

Tumbarello M, Rabagliati R, de Gaetano Donati K, Bertagnolio S, Montuori E, Tamburrini E, Tacconelli E, Cauda R.

BMC Infect Dis. 2004 Nov 6;4:46.

18.

Treatment for adult HIV infection: 2004 recommendations of the International AIDS Society-USA Panel.

Yeni PG, Hammer SM, Hirsch MS, Saag MS, Schechter M, Carpenter CC, Fischl MA, Gatell JM, Gazzard BG, Jacobsen DM, Katzenstein DA, Montaner JS, Richman DD, Schooley RT, Thompson MA, Vella S, Volberding PA.

JAMA. 2004 Jul 14;292(2):251-65.

PMID:
15249575
19.

National Hospital Discharge Survey: 2001 annual summary with detailed diagnosis and procedure data.

Kozak LJ, Owings MF, Hall MJ.

Vital Health Stat 13. 2004 Jun;(156):1-198.

20.

Voluntary HIV testing as part of routine medical care--Massachusetts, 2002.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2004 Jun 25;53(24):523-6.

Supplemental Content

Support Center